Company Active LTD

Company profile

Corin Limited

Corin Group: Connected Orthopaedic Insight

Corin is revolutionising orthopaedics by gaining, understanding and sharing insight at every stage of the arthroplasty experience. Our technologies are designed to enable surgeons to perform patient-specific procedures and gain a unique level of insight and understanding allowing them to manage their progress and achieve more positive results.

CRN
01910453
Founded
1985
Age
41

Overview

Legal name
CORIN LIMITED
Region
South West England
Registered address
UNIT 1 CORINIUM CENTRE
LOVE LANE INDUSTRIAL ESTATE
CIRENCESTER
UNITED KINGDOM
GL7 1YJ
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Corin Limited
CRN 01910453
2
Direct and ultimate controller Active LTD
Corin Holdings Limited
CRN 02879951

Company events

Reference milestones and recent Companies House filing stream events.

6 events
27 May
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Mar
2027

Accounts due

Accounts Due

Next accounts due date

13 May
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

22 Aug
2024

Accounts With Accounts Type Full

Accounts PDF pending

AA | Transaction MzQzMjM2NTg3M2FkaXF6a2N4 | Paper/PDF filed

Published 24 Aug 2024 06:59

01 May
1985

Incorporated

Inception

Company registered at Companies House

Public funding

6 awards
First funded
2008
Funded years
2008, 2009, 2011, 2012, 2013
Age at first award
22 years

Projects

2013 Collaborative R&D Lead participant

TICLE - TItanium CLEaning

1 Sep 2013 to 28 Feb 2015

Awarded
£69,042
Total cost £138,084

Additive Manufacture (AM) is being increasingly investigated within the orthopaedic industry for the production of optimised implant designs. The technology enables complex geometries to be generated which can also be better matched to the properties of bone. Such implants can minimise bone resorbtion and facilitate improved bone ingrowth, thus improving ...

2013 GRD Proof of Market Lead participant

Disposable Instruments

1 Sep 2013 to 31 May 2014

Awarded
£25,000
Total cost £41,689

Awaiting Public Project Summary

2012 GRD Proof of Concept Lead participant

E_SURF

1 May 2012 to 31 Oct 2013

Awarded
£99,998
Total cost £195,080

Clinical studies have shown that hip resurfacings provide improved patient function over total hip replacements (THR) with reduced recovery times; however, since 2008 there has been a large fall in the number of resurfacings performed. This is due to concern over ion release from metal-on-metal (MoM) implants leading to ALVAL (aseptic lymphocytedominated ...

2011 Collaborative R&D Lead participant

BERTI; Biomedical implant with Exceptional Resistance to Tribo-bio-corrosion and with Inherent antimicrobial properties

1 Oct 2011 to 31 Jan 2015

Awarded
£144,984
Total cost £435,127

The objective of project BERTI (Biomedical implant with Exceptional Resistance to Tribo-bio-corrosion and with Inherent antimicrobial properties) is to develop an innovative joint replacement with a coating that minimises polyethylene and metal wear debris, prevents metal ion release and promotes the release of antimicrobial agents. The project will deter...

2009 Collaborative R&D Lead participant

SHIELD

1 Oct 2009 to 30 Nov 2012

Awarded
£346,871
Total cost £788,344

Acetabular and femoral bone resorption is one of the few remaining clinical challenges to be addressed when considering the long term success of orthopaedic joint replacements, particularly in hip prostheses. Bone resorption around the proximal femoral stem and acetabular cup due to stress shielding contributes to bone loss and reduced bone mineral densit...

2008 Collaborative R&D

SMART-HIP: Smart Bioactive Nonocomposite Coatings for Enhanced Hip Replacement

1 Apr 2008 to 31 Jan 2012

Awarded
£0
Total cost £396,720

Metal on metal prostheses are currently an exciting new area for resurfacing and total hip replacements, reducing problems of osteolysis associated with standard metal on polymer prostheses. However, problems have been identified related to the biological response to the metal particles and metal ion release. The objective of this project is to develop an...

Product types

Collaborative R&D GRD Proof of Concept GRD Proof of Market